NDC 69683-202

DERMOSCRIBE SEBORRHEIC DERMATITIS

Sulfur, Salicylic Acid, Hydrocortisone

DERMOSCRIBE SEBORRHEIC DERMATITIS is a Topical Cream in the Human Otc Drug category. It is labeled and distributed by Dermoscribe Pty Ltd. The primary component is Hydrocortisone; Salicylic Acid; Sulfur.

• Product ID: 69683-202_d5f783f4-72f9-8541-e053-2a95a90a06bb
• NDC: 69683-202
• Product Type: Human Otc Drug
• Proprietary Name: DERMOSCRIBE SEBORRHEIC DERMATITIS
• Generic Name: Sulfur, Salicylic Acid, Hydrocortisone
• Dosage Form: Cream
• Route of Administration: TOPICAL
• Marketing Start Date: 2015-03-23
• Marketing Category: OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
• Application Number: part348
• Labeler Name: DERMOSCRIBE PTY LTD
• Substance Name: HYDROCORTISONE; SALICYLIC ACID; SULFUR
• Active Ingredient Strength: 1 g/100g; g/100g; g/100g
• Pharm Classes: Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 69683-202-11

60 g in 1 BOTTLE (69683-202-11)

• Marketing Start Date: 2015-03-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 69683-202-11 [69683020211]

DERMOSCRIBE SEBORRHEIC DERMATITIS CREAM

• Marketing Category: OTC monograph not final
• Application Number: part348
• Product Type: HUMAN OTC DRUG
• Marketing Start Date: 2015-03-23

Drug Details

Active Ingredients

Ingredient	Strength
SULFUR	3 g/100g

OpenFDA Data

• SPL SET ID: 2b6bf90b-5d42-4c08-afee-56e13122285e
• Manufacturer:
  • DERMOSCRIBE PTY LTD
• UNII:
  • O414PZ4LPZ
  • 70FD1KFU70
  • WI4X0X7BPJ
• RxNorm Concept Unique ID - RxCUI:
  • 1738574